Paper

Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

Published Mar 1, 2015 · DOI · M. Matsui, M. Petris, Y. Niki

The Journal of investigative dermatology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Study Snapshot

Omeprazole reduces melanogenesis by inhibiting ATP7A and enhancing degradation of tyrosinase in melanocytes.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

References

Citations